Pfizer planning yet another plant expansion

In yet another expansion of its manufacturing operations, Pfizer ($PFE) plans to lay out nearly $150 million to build a sterile manufacturing facility and warehouse at its site near Kalamazoo, MI. It is the third manufacturing project the drug giant has unveiled in the last couple of months.

The New York-based drugmaker intends to invest about $105.6 million on a sterile manufacturing operation and another $40.8 million on a warehouse, Michigan Live reports. The projects, for which Pfizer is seeking tax breaks, are expected to add only about 15 jobs but are part of about $800 million in investments the company has told the city could come over the next decade. It indicated it has invested about that much at the site in the last 10 years.

Pfizer site leader Robert Betzig told WKZO radio that the new technology investments will help the Pfizer site stay competitive with plants in low-cost countries like India and China.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

The 2,000-acre site in Kalamazoo County produces sterile injectables, nonsterile medications, biologicals, and other products, as well as 150 active pharmaceutical ingredients, steroids, antibiotics, and other Pfizer drugs, the company’s website indicates. It has about 2,100 employees at the site.

Pfizer is also seeking approval by authorities in Dublin, Ireland, to invest between €300 million and €400 million ($440.5 million) to build a 5-story, 34,500-square-meter (371,354-square-foot) biologics manufacturing unit at its Grange Castle manufacturing site. That  project is slated to result in 350 jobs and provide additional capacity for Pfizer arthritis drug Enbrel.

In June, Pfizer said it would spend $200 million to build a 175,000-square-foot facility at its campus in Andover, MA, also to produce complex biologics and vaccines.

- read the Michigan Live story
- get more from WKZO radio

Related Articles:
Pfizer expansion in Ireland would lead to 350 jobs
Pfizer planning Ireland biologics plant expansion
Pfizer adding $200M biologics facility to Andover, MA, campus


Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.